Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines

Abstract

Immune response against tissue-specific antigens is a hallmark of autoimmunity. Here the authors show that a single autoantigen-based nanomedicine can ameliorate pathology in a broad range of liver autoimmunity models without impairing host defenses, suggesting organ-wide tolerization.